Press release

First page Previous page 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | From 9 Next page Last page Next page

Title Date
SEPITONIC M3: a new clinical study confirms increased cutaneous oxygenation
SEPPIC conducted this new in vivo test on thirty volunteers, proving the effectiveness of SEPITONIC M3 after just two hours of treatment*, as it resulted in an almost 10% increase in the skin's partial pressure of oxygen(1).

January 12, 2015
SEPPIC Opens Doors of New Production Unit, 1st Sterile High-Volume Packaging Line for Vaccine Adjuvants and Injectables
Today SEPPIC, a leader in the global market for vaccine adjuvants, is launching operations at its new production unit for vaccine adjuvants and injectables in Castres, France. The ultramodern facility puts SEPPIC at the cutting edge of technology. It is now the only company producing large quantities of sterile pharmaceutical excipients¹ and packaging them in pouches with volumes as great as 200 L. SEPPIC will eventually be offering sizes up to 1,000 L.

October 30, 2014
SEPPIC presents Sea Shine, its new active ingredient – by BiotechMarine
Sea Shine, sourced in the pure waters of the Brehat archipelago - Brittany, France, is the fruit of a comprehensive and innovative research on the mechanisms involved in skin pigmentation.

March 28, 2014
SEPPIC launches in the cosmetic hair-care market
SEPPIC is already recognized for its expertise in active ingredients, thickening products and emulsifiers for skincare, and is now launching into the haircare field with high-performance ingredients.

March 14, 2014
SEPPIC obtains EXCiPACT™ Certification
In December 2013, SEPPIC became the first French company and only the fourth company worldwide to obtain EXCiPACT™ certification.

March 5, 2014
First page Previous page 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | From 9 Next page Last page Next page

Print Send to a friend Bookmark this page Network

Text size        T- T+